Abstract. Inflammation and thrombogenesis have been suggested as possible causes for cardiovascular events in patients suffering from metabolic syndrome (MS). The primary objective of this study was to determine the relationship between red blood cell (RBC) or white blood cell (WBC) subtypes and MS. The secondary objective was to reveal any gender differences inherent to this association. Body mass index (BMI), blood pressure, serum high-density lipoprotein cholesterol, triglycerides, and glucose were measured. The numbers of WBC subtypes and RBCs were determined in healthy adults. In male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes was elevated in the MS patients (P<0.05). In the male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in accordance with the metabolic component count (P<0.05). RBC, monocyte, eosinophil, and basophil counts did not differ in accordance with metabolic component counts (r = 0.406, r = 0.304, r = 0.366; P<0.05). In the female subjects, we determined there to be no differences in the numbers of RBC and WBC subtypes in the MS patients, in accordance with metabolic component counts. The numbers of total leukocytes, neutrophils, and lymphocytes were elevated in the male MS subjects in this study, and these counts increased in accordance with the metabolic component counts. In the female subjects in this study, we determined there to be no association between RBC and WBC subtype counts with MS.
THE National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) established the clinical criteria for metabolic syndrome (MS). These criteria include: central obesity, hypertension, glucose intolerance, elevated triglyceride (TG) levels, and low high-density lipoprotein cholesterol (HDL-C) [1, 2] . MS is a particularly important region of study because it is closely related to ischemic heart disease, and a strong possibility exists that ischemic heart disease might be prevented by controlling MS [3] [4] [5] [6] [7] .
According to a 2003 report submitted by the Korea National Statistical Office, deaths as the result of cardiovascular disease ranked 2nd in the nation, at 124.7 deaths per 100,000 persons. Deaths from ischemic heart disease, in particular, have increased abruptly in recent years, with 10.4 deaths in 1990, 21.5 deaths in 2000, and 24.6 deaths per 10,000 persons in 2003 [8] . These results evidence a trend opposite that seen in westernized countries [9] , in which deaths from ischemic heart disease have manifested a decreasing trend. In order to reduce the incidence and mortality associated with ischemic heart disease, MS research appears to be essential, as increasing evidence suggests that MS may be significantly associated with an increased risk of ischemic heart disease [1, 2] . Specific studies of the Korean population have yielded unique results, but the results of these studies tend to be applicable to other countries, as Koreans exhibit very little genetic diversity, primarily due the ethnic homogeneity inherent to the Korean population.
Activation of inflammatory processes and chronic activation of thrombosis have both been suggested as causes for the observed association between MS and ischemic heart disease [10] [11] [12] . Increments of inflam-matory factors such as C-reactive protein, interleukin (IL)-6, tumor necrosis factor (TNF)-a, and thrombosis factors including plasminogen activator-1 and the tissue-type plasminogen activator, have all been suggested to play roles in this association [10] [11] [12] . Although several studies have addressed the relationship between inflammatory or thrombotic factors and MS, only a relatively few studies have attempted to characterize the association between MS and WBC subtypes and RBC counts. Several studies have indicated that elevated WBC and RBC counts are associated with risk for ischemic heart disease [13] [14] [15] . However, systemic studies indicating a relationship between WBC subtypes and RBC counts, which are frequently assessed in the clinical field, with the clustered features of MS, have been few and far between. A WBC subtype and RBC count is a fairly inexpensive procedure, and can provide important information for patients. Therefore, the clear elucidation of an association between these hematological parameters and MS would definitely prove useful in clinical applications.
The specific primary objective of this investigation was to characterize the relationship existing between RBC or WBC subtypes and MS. The secondary objective of this investigation was to establish that a gender difference is inherent to this association.
Patients and Methods

Study subjects
The subject group included 399 participants (>20 years old), all of whom had undergone a general health check-up at a health promotion center from March to July 2004, at the Korea University Guro Hospital. Of these 399 participants, 313 completed self-report questionnaires containing questions regarding past medical history and smoking status. The results for smoking history were subdivided into non-smokers, ex-smokers, and current smokers.
Due to the fact that blood cell counts might have been influenced by several medical disorders, any subjects with pulmonary, hepatic, renal, malignancies, infectious disorders, or hematological diseases were excluded from this study. Patients exhibiting WBC counts in excess of 11,000/mm 3 , or hemoglobin levels below 10 gm/dl, were also excluded from this study. After considering the exclusion criteria, a total of 299 subjects were finally recruited into this study.
An institutional review committee approved the clinical research protocols applied in this study, and all subjects provided informed written consent before participation. The tests in this study were conducted between 09 : 30 am and 11 : 30 am, after a 12-hour fasting period.
Study methods
MS was defined by the presence of 3 or more of the following 5 risk factors: 1) obesity (Body Mass Index (BMI)>25 kg/m 2 ), 2) serum triglyceride (TG) levels in excess of 150 mg/dl (1.69 mmol/l); 3) serum HDL cholesterol (HDL-C) levels below 40 mg/dl (1.03 mmol/l) for males, and below 50 mg/dl (1.29 mmol/l) for females, 4) systolic/diastolic blood pressure in excess of 130/85 mmHg or history of antihypertensive treatment, and 5) fasting plasma glucose in excess of 110 mg/dL (6.1 mmol/l) or history of antidiabetes treatment.
BMI was calculated by the patient's weight (kilograms) divided by height (meters squared). As waist circumference, one of the NCEP ATP III criteria, was not appropriate for use in the Korean population, we utilized BMI for obesity assessment, in accordance with the accepted Asia-Pacific obesity criteria [16] .
Blood pressure was measured in the patient's right arm, using an appropriately-sized cuff and a standard mercury sphygmomanometer, with the subjects in a sitting position. After measuring blood pressure, venous blood samples were taken, after 12 hours of fasting.
The numbers of WBC subtypes and RBCs were computed with an autoanalyzer (Sysmex XE-2100, Kobe, Japan). Serum TG, HDL-C, and glucose levels were measured via the enzymatic method, using a chemistry analyzer (Hitachi 747, Tokyo, Japan).
Statistical analysis
The continuous variables measured in this study were expressed as mean values ± standard deviation. In order to compare the mean values of the hematological parameters with the metabolic components, we utilized the general linear model and two-way ANOVA, after controlling for age, gender, and smoking history. Partial Spearman's correlations (adjusted for age and smoking status) were estimated for various blood cell counts with the numbers of MS components. SPSS version 12.0 (SPSS Inc., Chicago, Illinois, USA) software was utilized for all of the analyses. All of the Pvalues reported in the statistical tests were two-tailed, and a P value of <0.05 was considered to denote statistically significant differences.
Results
The demographic and clinical characteristics of the subjects are shown in Table 1 . The subject group consisted of 299 persons (male: 137, female: 162). The mean ages of the subjects were 43.5 ± 11.1 for the males, and 41.3 ± 11.0 for the females. Smoking status, MS components, and hematological parameters differed depending on gender.
The RBC and WBC subtype counts by gender, after adjusting for smoking status and age, are shown in Table 2 . RBC and monocyte counts were determined to be significantly elevated in the male subjects (P<0.01). Table 3 shows the association of MS with the RBC and WBC subtype counts after adjusting for smoking status and age. In the male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in the MS patients (P<0.05). RBC, monocytes, eosinophils, and basophil counts did not differ significantly among the subjects. In the female subjects, we determined there to be no significant differences in the RBC and WBC subtype counts between the MS and non-MS subjects.
The numbers of RBCs and WBC subtypes according to the numbers of metabolic components, after adjusting for smoking status and age, are shown in Table 4 . In the male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in accordance with the metabolic component counts (P<0.05). RBC, monocyte, eosinophil, and basophil counts did not differ according to metabolic component counts. In the female subjects, we determined there to be no differences in RBC and WBC subtype counts in accordance with metabolic component counts. The partial correlation coefficients of the MS components and total leukocyte (r = 0.406), neutrophil (r = 0.304), and lymphocyte (r = 0.366) counts in males, after adjusting for age and smoking status, are shown in Fig. 1 . Total leukocyte, neutrophil, and lymphocyte counts were elevated in accordance with the number of MS components (P<0.05).
Discussion
The results of this study indicated that the numbers of total leukocytes, neutrophils, and lymphocytes increased significantly with clustered features of MS in male subjects, as well as with increased metabolic components. The mechanism underlying this increase in the WBC counts in MS patients remain somewhat unclear, although it has been suggested that the association between insulin resistance and WBC might be responsible. However, insulin resistance increases the counts of proinflammatory cytokines including Il-6 and TNF-a, demonstrating that the numbers of WBCs and some specific WBC subtypes can be increased by the influence of proinflammatory cytokines [11, 12, 17, 18] .
An association between elevated WBC counts and MS has been found to exist in several previous studies [17, 19] . However, there remains some controversy as to which WBC subtypes predict increased risk of MS or cardiovascular disease. Some studies have shown that elevated monocyte counts are associated with increased risks, whereas other studies have reported that high neutrophil counts were predictive of greater cardiovascular risk [20] [21] [22] . One Japanese study found a significant correlation between both neutrophil and eosinophil counts and coronary heart disease [23] , and another recently conducted study asserted that both high neutrophil and low lymphocyte counts constituted independent predictors of myocardial infarction [20] . Although it is difficult to explain which WBC subtypes predict increased risk of MS or cardiovascular disease, a recent study proposed that proinflammatory, proatherogenic cytokines and chemokines released by perivascular white adipose tissue could explain at least some part of this phenomenon [24] . They reported human adipose tissue exerts a strong chemotactic effect on monocytes, granulocytes, and T lymphocytes [24] . Therefore human adipose tissue could play an important role in developing MS or cardiovascular disease. It remains unclear as to why WBC counts were correlated with MS only in the male subjects evaluated in this study. Although the reason for these observed gender differences remains to be elucidated, the vascular protective effects of estrogen [25, 26] might be involved in this discrepancy. Morbidity and mortality due to coronary heart disease is much higher in men than women. Estrogen, a female sex hormone is widely believed to be responsible for protection of women from atherosclerosis by decreasing the inflmatory cell adhesion as well as vasodilatation or NO production increase [27] . Estrogen has also been shown to reduce various adhesion molecules and chemotactic proteins that are involved in the pathogenesis of atherosclerosis [28] . These estrogen effects in women could explain our gender discrepancy, which WBC is increased only in male MS subjects.
The results of some studies also appear to suggest that MS components increase RBC production [15, [29] [30] [31] [32] . The mechanisms responsible for this increase in RBC counts in cases of metabolic syndrome remain unclear. Both insulin-related [33] and insulin nonrelated mechanisms [34] have been suggested as possible causes of this phenomenon. Elevated RBC levels result in an increased release of oxygen from the organs [35, 36] , and a concomitant attenuation of micro vascular circulation [37, 38] . Therefore, an elevated RBC count would seem to be a logical cause of ischemic heart disease. However, the results of our study indicated that no relationship exists between MS and RBC.
A study investigated in Taiwan Chinese population showed close relation between MS and RBC as well as WBC [39] . However, they did not exclude the population whose hemoglobin level was low. In our study, however, subjects exhibiting hemoglobin levels below 10 gm/dl were excluded, in order to exclude any patients who suffered from hemoglobin-influencing medical disorders. Therefore, the possibility that such severe diseases may have been included in these other studies cannot be wholly excluded. Future studies should also be conducted using only healthy subjects, in whom it has been confirmed that no such hemoglobinrelated medical disorders exist.
Smoking was also controlled in this study, as it can be a strong determinant of both WBC subtypes [25, 26] and RBC counts [15, 40] .
Despite its design advantages, this study suffered from some limitations. Firstly, the study was conducted with a cross-sectional design, making it difficult to determine causality with regard to the observed relationship. Secondly, the study population was not sufficiently large to come to a more confident conclusion.
In conclusion, the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in male MS subjects in this study, and these elevated levels increased in accordance with the numbers of detected metabolic components. In female subjects, however, RBCs and WBC subtypes could not be significantly associated with MS.
